Literature DB >> 11205710

Sertoli-Leydig cell tumor.

T Lantzsch1, S Stoerer, K Lawrenz, J Buchmann, H G Strauss, H Koelbl.   

Abstract

Sertoli-Leydig cell tumors belong to the group of sex-cord stromal tumors of the ovary. They account for less than 0,5% of all ovarian neoplasms. The majority of these tumors are benign, and almost all are localised unilaterally. Herewith, we describe an ovarian Sertoli-Leydig cell tumor in an 11-year-old girl. Serum levels of estradiol and progesterone were mildly elevated. while testosterone and androstendion levels were raised to around three- and sevenfold upper normal limit respectively on presentation. A left salpingo-oophorectomy was performed. Microscopically, the tumor was intermediately differentiated. At 6 months follow-up, there was neither clinical nor sonographical evidence of recurrence, and almost all sex hormone levels had returned to within normal range. Treatment of this pathological entity has to be individualized according to patient age, stage of tumor and degree of differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11205710     DOI: 10.1007/s004040000114

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  9 in total

1.  A rare ovarian tumor - Sertoli-Leydig cell tumor with heterologous element.

Authors:  Rimpy Tandon; Poonam Goel; Pradip Kumar Saha; Navneet Takkar; R P S Punia
Journal:  MedGenMed       Date:  2007-11-28

2.  Retiform Sertoli-Leydig cell tumor of ovary in a 9-year-old girl: case report and review of the literature.

Authors:  Weizhen Lou; Dongyan Cao; Jiaxin Yang; Lina Guo; Keng Shen
Journal:  Int J Clin Oncol       Date:  2011-02-24       Impact factor: 3.402

3.  Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Francis Zheng Yi Yee; Grace Hwei Ching Tan; Claramae Shulyn Chia; Khee Chee Soo; Melissa Ching Ching Teo
Journal:  Pleura Peritoneum       Date:  2017-08-24

4.  Clinicopathological analysis of ovarian sertoli-leydig cell tumor with postmenopausal vaginal bleeding as the first symptom: A case report.

Authors:  Li-Juan Huang; Liang-Yan Shi; Jie Duan
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

5.  Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and DICER1 Mutations: Case Report and Literature Review.

Authors:  Yanglin Ni; Xuan Zhou; Ling Wu; Ping Wu; Ying Liu; Yinnan Li; Li Cai; Xueshu Fu; Chunhua Zhang
Journal:  Pharmgenomics Pers Med       Date:  2021-08-03

6.  Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients.

Authors:  Guangning Wang; Ran Zhang; Chuan Li; Aiping Chen
Journal:  J Ovarian Res       Date:  2021-11-04       Impact factor: 4.234

7.  The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.

Authors:  Yemin Wang; Jiamin Chen; Winnie Yang; Fan Mo; Janine Senz; Damian Yap; Michael S Anglesio; Blake Gilks; Gregg B Morin; David G Huntsman
Journal:  Neoplasia       Date:  2015-08       Impact factor: 5.715

8.  A case of successful salvage chemotherapy of recurrent ovarian sertoli-leydig cell tumor.

Authors:  Soyi Lim; Na-Rae Kim; Kwang-Beom Lee
Journal:  Obstet Gynecol Sci       Date:  2013-05-16

9.  A Rare Case of Intra-Endometrial Leiomyoma of Uterus Simulating Degenerated Submucosal Leiomyoma Accompanied by a Large Sertoli-Leydig Cell Tumor.

Authors:  Kyungah Jeong; Sa Ra Lee; Sanghui Park
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.